Geode Capital Management, LLC Insmed Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,813,384 shares of INSM stock, worth $283 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,813,384

Previous 3,640,720 4.74%

Holding current value

$283 Million

Previous $244 Million 14.12%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$62.0 - $79.01 $10.7 Million - $13.6 Million	172,664 Added 4.74%	3,813,384 $278 Million
Q2 2024 Aug 09, 2024	BUY	$22.0 - $69.71 $10.5 Million - $33.2 Million	476,969 Added 15.08%	3,640,720 $244 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $2.43 Million - $2.83 Million	94,373 Added 3.07%	3,163,751 $85.8 Million
Q4 2023 Feb 13, 2024	BUY	$23.42 - $31.74 $4.58 Million - $6.21 Million	195,681 Added 6.81%	3,069,378 $95.1 Million
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $3.38 Million - $4.58 Million	170,154 Added 6.29%	2,873,697 $72.6 Million
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $1.28 Million - $1.64 Million	77,868 Added 2.97%	2,703,543 $57 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $2.1 Million - $2.81 Million	129,286 Added 5.18%	2,625,675 $44.8 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $5.98 Million - $8.15 Million	352,106 Added 16.42%	2,496,389 $49.9 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $990,025 - $1.34 Million	47,415 Added 2.26%	2,144,283 $46.2 Million
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $366,766 - $552,405	-21,486 Reduced 1.01%	2,096,868 $41.4 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $1.23 Million - $1.7 Million	60,362 Added 2.93%	2,118,354 $49.8 Million
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $1.28 Million - $1.66 Million	49,495 Added 2.46%	2,057,992 $56.1 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $2.47 Million - $3.23 Million	109,767 Added 5.78%	2,008,497 $55.3 Million
Q2 2021 Aug 13, 2021	BUY	$24.17 - $36.01 $4.24 Million - $6.31 Million	175,316 Added 10.17%	1,898,730 $54 Million
Q1 2021 May 12, 2021	BUY	$32.28 - $44.3 $4.09 Million - $5.62 Million	126,782 Added 7.94%	1,723,414 $58.7 Million
Q4 2020 Feb 12, 2021	BUY	$31.45 - $40.54 $2.69 Million - $3.46 Million	85,394 Added 5.65%	1,596,632 $53.2 Million
Q3 2020 Nov 13, 2020	SELL	$26.0 - $34.5 $549,146 - $728,674	-21,121 Reduced 1.38%	1,511,238 $48.6 Million
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $2.85 Million - $5.95 Million	202,175 Added 15.2%	1,532,359 $42.2 Million
Q1 2020 May 14, 2020	BUY	$13.63 - $33.98 $1.57 Million - $3.91 Million	114,973 Added 9.46%	1,330,184 $21.3 Million
Q4 2019 Feb 13, 2020	BUY	$16.12 - $24.98 $756,269 - $1.17 Million	46,915 Added 4.02%	1,215,211 $29 Million
Q3 2019 Nov 12, 2019	BUY	$15.49 - $25.78 $1.03 Million - $1.72 Million	66,727 Added 6.06%	1,168,296 $20.6 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $3.31 Million - $4.64 Million	144,017 Added 15.04%	1,101,569 $28.2 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $1.27 Million - $2.84 Million	91,063 Added 10.51%	957,552 $27.8 Million
Q4 2018 Feb 13, 2019	BUY	$11.6 - $18.7 $638,301 - $1.03 Million	55,026 Added 6.78%	866,489 $11.4 Million
Q3 2018 Nov 13, 2018	BUY	$18.95 - $28.08 $729,707 - $1.08 Million	38,507 Added 4.98%	811,463 $16.4 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $834,540 - $1.24 Million	41,727 Added 5.71%	772,956 $18.3 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $851,267 - $1.29 Million	39,247 Added 5.67%	731,229 $16.5 Million
Q4 2017 Feb 13, 2018	BUY	$26.43 - $31.78 $520,935 - $626,383	19,710 Added 2.93%	691,982 $21.6 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.64 Million - $4.4 Million	141,121 Added 26.57%	672,272 $21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	531,151	531,151 $9.11 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Insmed Inc Transaction History